15 completed, 2 unknown, 1 recruiting, 1 withdrawn. 7 Phase 4, 5 Phase 2, 4 Phase 1, 2 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 6, Unknown 1 |
| Phase 2 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Nadolol: new trials by email Literature Review of Nadolol trials Research Report on Nadolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders clenbuterol (CST-103), nadolol (CST-107), matching placebo - Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia | Phase 2 | Completed | CuraSen Therapeutics, Inc. | 41 | 2021-06-28 | 2024-12-02 |
| Impact of Beta-blockers on Physical Function in HFpEF Beta blockers - Heart Failure, Heart Failure, Diastolic | Phase 4 | Completed | Weill Medical College of Cornell University | 9 | 2021-04-01 | 2023-09-08 |
| Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF Beta blockers - Heart Failure, Heart Failure, Diastolic | Phase 4 | Completed | Weill Medical College of Cornell University | 9 | 2021-04-01 | 2024-04-09 |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| Exercise as an Immune Adjuvant for Allogeneic Cell Therapies Exercise, Isoproterenol, Placebo - Leukemia, Hematopoetic Stem Cell Transplantation | Early Phase 1 | Recruiting | University of Arizona | 200 | 2018-01-24 | 2026-06-05 |
| Nadolol Versus Propranolol in Children With Infantile Hemangiomas Nadolol, Propranolol - Infantile Hemangioma | Phase 3 | Completed | The Hospital for Sick Children | 74 | 2015-09-01 | 2020-10-28 |
| Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction Nadolol, Placebo - Smoking Cessation | Phase 2 | Completed | Invion, Inc. | 155 | 2014-03-01 | 2017-02-01 |
| Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Nadolol, Placebo - Mild Persistent Asthma, Uncomplicated | Phase 2 | Unknown | Invion, Inc. | 60 | 2013-03-01 | 2016-08-09 |
| Nadolol for Proliferating Infantile Hemangiomas Nadolol - Infantile Hemangioma | Phase 2 | Completed | The Hospital for Sick Children | 20 | 2009-11-01 | 2021-08-19 |
| Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding Nadolol - Liver Cirrhosis and Hepatoma., Gastric Variceal Bleeding | Phase 4 | Unknown | Taipei Veterans General Hospital, Taiwan | 120 | 2007-04-01 | 2010-06-08 |
| Oral Nadolol for the Treatment of Adults With Mild Asthma nadolol - Asthma | Phase 1 / Phase 2 | Completed | Invion, Inc. | 10 | 2007-01-01 | 2016-05-11 |
| Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg, Corzide® Tablets 80 mg/5 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 42 | 2006-08-01 | 2024-04-23 |
| Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg, Corzide® Tablets 80 mg/5 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 66 | 2006-07-01 | 2024-04-23 |
| Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE Thalidomide - Gastrointestinal Hemorrhage, Portal Hypertension | Phase 3 | Withdrawn | The Cleveland Clinic | 2006-05-01 | 2013-07-31 | |
| A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding carvedilol, nadolol + ISMN - Variceal Rebleeding | Phase 4 | Completed | E-DA Hospital | 121 | 2005-03-01 | 2010-10-26 |
| A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis Ligation of varices, Nadolol - Variceal Bleeding, Cirrhosis | Phase 4 | Completed | National Science and Technology Council, Taiwan | 140 | 2004-12-01 | 2009-06-16 |
| Drug and Non-Drug Treatment Of Severe Migraine Propranolol or nadolol, Placebo control, Behavioral Migraine Management (BMM) - Migraine Headache | Phase 4 | Completed | Ohio University | 232 | 2001-07-01 | 2016-11-22 |
| Secondary Prophylaxis After Variceal Bleeding in Non-Responders esofagic varices ligation, Nadolol, Isosorbide mononitrate - Gastrointestinal Hemorrhage, Portal Hypertension | Phase 4 | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 50 | 2000-11-01 | 2007-03-21 |
| Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions Nadolol (1 x 80 mg) Tablets (Invamed, Inc), Corgard (1 x 80 mg) Tablets (Bristol Laboratories) - High Blood Pressure, Migraine Headaches | Phase 1 | Completed | Sandoz | 34 | 1994-07-01 | 2017-03-28 |
Fibrosis (3) · Gastrointestinal Hemorrhage (2) · Heart Diseases (2) · Heart Failure (2) · Heart Failure, Diastolic (2) · Hemangioma, Capillary (2) · Hypertension (2) · Hypertension, Portal (2) · Migraine Disorders (2) · Asthma (1) · Carcinoma, Hepatocellular (1) · Chest Pain (1) · Cognitive Dysfunction (1) · Hemangioma (1) · Leukemia (1)
Invion, Inc. (3) · Mylan Pharmaceuticals Inc (2) · The Hospital for Sick Children (2) · Weill Medical College of Cornell University (2) · CuraSen Therapeutics, Inc. (1) · E-DA Hospital (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · National Science and Technology Council, Taiwan (1) · Ohio University (1) · Sandoz (1) · Taipei Veterans General Hospital, Taiwan (1) · The Cleveland Clinic (1) · University of Arizona (1) · University of Utah (1)
United States (11) · Canada (2) · Australia (1) · China (1) · New Zealand (1) · Spain (1) · United Kingdom (1)
James D Carlson, Pharm. D. (2) · Parag Goyal, MD (2) · Adam P Bress, PharmD, MS (1) · Elena Pope, MD (1) · Elena Pope, MD, MSc (1) · Kenneth A Holroyd, Ph.D. (1) · Mario Castro, M.D. (1) · Ming-Chih Hou, MD (1) · Nicola A Hanania, MD (1) · Nicola A. Hanania, MD, MS (1) · Terry L. Wolff, D.O. (1)
PMID 20880898, PMID 33891615, PMID 34747977, PMID 36189306, PMID 36719647, PMID 37077913, PMID 38592213, PMID 40311885, PMID 40574863, PMID 40940923, PMID 41194247, PMID 41538301, PMID 41776652, PMID 42845554
K76AG064428 (1), R01CA277493 (1)